Papua New Guinea vs Yemen: Prevalence rate of hypertension in women aged 30-79
Papua New Guinea
30.1
in 2019
Yemen
29.6
in 2019
Papua New Guinea rank
156th
Yemen rank
158th
Prevalence rate of hypertension in women aged 30-79 over time
- Papua New Guinea
- Yemen
How they compare
Papua New Guinea currently reports 30.1 against 29.6 in Yemen, a difference of 0.5.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Yemen ahead.
Papua New Guinea ranks 156th and Yemen ranks 158th of 195 countries.
Yemen has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Papua New Guinea | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 23.39 | 31.82 | 8.43 | Yemen |
| 2000s | 22.83 | 30.64 | 7.81 | Yemen |
| 2010s | 27.23 | 29.92 | 2.69 | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Papua New Guinea or Yemen?
- Papua New Guinea, at 30.1 against 29.6 in Yemen as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Papua New Guinea and Yemen?
- 0.5, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Yemen?
- 30 years are reported by both, from 1990 to 2019.
- How do Papua New Guinea and Yemen rank globally for prevalence rate of hypertension in women aged 30-79?
- Papua New Guinea ranks 156th and Yemen ranks 158th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.